Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inogen, Inc - Common Stock (NQ: INGN )

8.330 +0.380 (+4.78%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 408,849
Open 7.950
Bid (Size) 7.790 (1)
Ask (Size) 8.830 (1)
Prev. Close 7.950
Today's Range 7.940 - 8.560
52wk Range 6.140 - 13.33
Shares Outstanding 23,121,377
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's Going On With MedTech Focused Inogen Stock On Wednesday?
Inogen beat Q4 earnings and revenue estimates, citing strong B2B demand. Analysts see potential but flag supply challenges and restructuring risks. 
Via Benzinga
Inogen Announces Fourth Quarter and Full Year 2024 Financial Results
From Inogen, Inc.
Via Business Wire

Performance

YTD
-9.36%
-9.36%
1 Month
-33.52%
-33.52%
3 Month
-14.21%
-14.21%
6 Month
-32.11%
-32.11%
1 Year
+25.26%
+25.26%

More News

Read More
Earnings Scheduled For February 25, 2025
Via Benzinga
Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West
From Inogen, Inc.
Via Business Wire
Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell
From Inogen, Inc.
Via Business Wire
Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
From Inogen, Inc.
Via Business Wire
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
From Inogen, Inc.
Via Business Wire
Inogen Announces Third Quarter 2024 Financial Results
From Inogen, Inc.
Via Business Wire
Inogen to Present at Upcoming Investor Conferences
From Inogen, Inc.
Via Business Wire
Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024
From Inogen, Inc.
Via Business Wire
Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC
From Inogen, Inc.
Via Business Wire
Inogen Appoints Eric Pauls as Vice President of Sales, North America
From Inogen, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Inogen Announces Second Quarter 2024 Financial Results
From Inogen, Inc.
Via Business Wire
3 Stocks Under $10 With the Potential for Massive Gains
Via InvestorPlace
Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024
From Inogen, Inc.
Via Business Wire
Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development
From Inogen, Inc.
Via Business Wire
Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio
From Inogen, Inc.
Via Business Wire
INGN Stock Earnings: Inogen Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Inogen Announces First Quarter 2024 Financial Results
From Inogen, Inc.
Via Business Wire
Inogen to Report First Quarter 2024 Financial Results on May 7, 2024
From Inogen, Inc.
Via Business Wire
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference
From Inogen, Inc.
Via Business Wire
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Inogen, Inc.
Via Business Wire
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.